ATE349527T1 - Gruppe a streptokokken-impfstoff - Google Patents

Gruppe a streptokokken-impfstoff

Info

Publication number
ATE349527T1
ATE349527T1 AT98946991T AT98946991T ATE349527T1 AT E349527 T1 ATE349527 T1 AT E349527T1 AT 98946991 T AT98946991 T AT 98946991T AT 98946991 T AT98946991 T AT 98946991T AT E349527 T1 ATE349527 T1 AT E349527T1
Authority
AT
Austria
Prior art keywords
group
immunogenic
streptococci
immune response
peptide
Prior art date
Application number
AT98946991T
Other languages
English (en)
Inventor
James B Dale
Original Assignee
Univ Tennessee Res Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tennessee Res Foundation filed Critical Univ Tennessee Res Foundation
Application granted granted Critical
Publication of ATE349527T1 publication Critical patent/ATE349527T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT98946991T 1997-09-12 1998-09-14 Gruppe a streptokokken-impfstoff ATE349527T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5863597P 1997-09-12 1997-09-12

Publications (1)

Publication Number Publication Date
ATE349527T1 true ATE349527T1 (de) 2007-01-15

Family

ID=22018009

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98946991T ATE349527T1 (de) 1997-09-12 1998-09-14 Gruppe a streptokokken-impfstoff

Country Status (8)

Country Link
EP (1) EP1003875B1 (de)
JP (1) JP2001515723A (de)
AT (1) ATE349527T1 (de)
AU (1) AU751009B2 (de)
CA (1) CA2303478C (de)
DE (1) DE69836744T2 (de)
ES (1) ES2280101T3 (de)
WO (1) WO1999013084A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939087B2 (en) 2000-10-27 2011-05-10 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from Streptococcus groups A & B
GB2370770B (en) * 2001-01-03 2005-06-01 Simon Connolly Uses of Streptococcus Vaccines
ATE557041T1 (de) 2001-05-18 2012-05-15 Us Gov Health & Human Serv Peptid-vakzinen gegen streptokokken der gruppe a
AU2008203277B2 (en) * 2001-05-18 2011-07-07 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention, Technology Transfer Office Peptide vaccines against group A streptococci
AU2011232787B2 (en) * 2001-05-18 2013-05-02 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention, Technology Transfer Office Peptide vaccines against group A streptococci
WO2003004650A2 (en) 2001-07-06 2003-01-16 Shire Biochem Inc. Group b streptococcus antigens and corresponding dna fragments
AU2002365184A1 (en) * 2001-10-26 2003-07-30 Id Biomedical Corporation Of Washington Efficient protein expression system
US7255867B2 (en) 2002-11-15 2007-08-14 Id Biomedical Corporation Of Quebec Vaccine
US7709009B2 (en) 2003-07-31 2010-05-04 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for streptococcus pyogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
WO2006078318A2 (en) 2004-07-29 2006-07-27 Novartis Vaccines And Diagnostics Inc. Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
EP1807446A2 (de) 2004-10-08 2007-07-18 Novartis Vaccines and Diagnostics, Inc. Immunogene und therapeutische zusammensetzungen für pyogene streptokokken
EP1857640A3 (de) 2006-05-10 2010-05-05 Silicon Fire AG Neuartiger kaskadierter Kraftwerksprozess und Verfahren zum Bereitstellen von reversibel einsetzbaren Wasserstoffträgern in einem solchen Kraftwerksprozess
US8287885B2 (en) 2007-09-12 2012-10-16 Novartis Ag GAS57 mutant antigens and GAS57 antibodies
NZ586430A (en) 2007-12-21 2012-09-28 Novartis Ag Mutant forms of streptolysin o (slo)
CL2013002782A1 (es) * 2013-09-27 2014-04-25 Univ Pontificia Catolica Chile Formulación inmunogénica para inducir la respuesta inmune en un sujeto que comprende una mezcla de bacterias no patógenas que expresan cada una un segmento hipervariable de la proteína m de diferentes streptococcus pyogenes; uso de la formulación para producir una vacuna; método para producir vacuna

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69331733T2 (de) * 1992-09-16 2002-08-22 The University Of Tennessee Research Corp., Knoxville Rekombinantes vielwertiges m-protein-vakzin

Also Published As

Publication number Publication date
DE69836744T2 (de) 2007-10-04
WO1999013084A9 (en) 1999-05-27
EP1003875A1 (de) 2000-05-31
EP1003875B1 (de) 2006-12-27
JP2001515723A (ja) 2001-09-25
CA2303478C (en) 2008-09-02
WO1999013084A1 (en) 1999-03-18
AU751009B2 (en) 2002-08-08
DE69836744D1 (de) 2007-02-08
CA2303478A1 (en) 1999-03-18
AU9388498A (en) 1999-03-29
ES2280101T3 (es) 2007-09-01

Similar Documents

Publication Publication Date Title
DE69836744D1 (de) Gruppe a streptokokken-impfstoff
DE69522216D1 (de) Zielzellen-bindende chimäre Peptide
DE60035419D1 (de) Antigene peptide aus neisseria
EP1619202A3 (de) Immunotherapeutische Methoden mit Verwendung von WT-1 and GATA-1 Epitopen
HUP9901186A2 (hu) Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
IL102687A0 (en) Method for enhancing immunogenicity
NZ331829A (en) Clostridium perfringens vaccines
DK1265914T3 (da) WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme
DK0477231T3 (da) Immunoaktive peptider og antistoffer, og deres anvendelse til anti-allergibehandling
CY1107706T1 (el) Πεπτιδια ανταγωνιστες καρκινοεμβρυονικου αντιγονου (cea)
ATE557041T1 (de) Peptid-vakzinen gegen streptokokken der gruppe a
HUT68554A (en) Immunogenic carrier system eliciting an immuneresponse against gnrh, recombinant dna sequence coding for it and its use
BR9710975A (pt) Genes de proteìna de adesão de superfìcie exposta de 120 kda imunodominante de ehrlichia chaffeensis
NZ332565A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
DE60234475D1 (de) Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens
EP0236977A3 (de) Impfstoffe gegen Rindervirus-Diarrhoe und Schweine-Cholera
NO20005081D0 (no) Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav
CA2128407A1 (en) Synthetic peptides for a rubella vaccine
PE20010237A1 (es) GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS OmpH, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS
WO2002044202A3 (fr) Peptides immunogeniques mutes derives de r9m, polynucleotides les codant et leurs usages therapeutiques
PE20010316A1 (es) GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS, PEPTIDOS Y PROTEINAS FlgE RELACIONADOS Y SUS USOS
PE20010239A1 (es) Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos
ATE312923T1 (de) Moraxella catarrhalis basb034 polypeptide und verwendungen davon
NZ219192A (en) Peptides related to p97 melanoma-associated peptide, recombinant virus and vaccines
GB9910375D0 (en) Vaccine composition

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties